Startup · $1.6m raised

Endo Axiom

oral Insulin Startup

Investors

Every investor coverage indicates participated in a round Endo Axiom raised.

Investor	Rounds	Invested
Australian Government	Grant	-
MTPConnect	Accelerator · Grant	-
University of Sydney	Accelerator	-

What Endo Axiom bought

Companies Endo Axiom acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Endo Axiom is not recorded as having acquired anything.

Coverage

Stories naming Endo Axiom. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

14 deals

Life sciences investor MTPConnect injects $12 million into 14 drug and device startups

MTPConnect's government-backed accelerator program has awarded $12.07 million in non-dilutive grants to 14 Australian drug and device companies, which will also receive mentoring and support from partners including CSL and Roche Diagnostics.

Startup Daily 23 Jun 2025 Anaxis Pharma Argenica Therapeutics Aspecthera Atherid Therapeutics CathRx Ltd Endo Axiom I D & E Inosi Therapeutics Nanomedx ProGenis Pharmaceuticals Theia Medical Venstra Medical Wavewise Analytics ZiP Diagnostics CSL Medical Research Future Fund MTPConnect Stuart Dignam

Also SmartCompany·@AuManufacturing

8 deals

University of Sydney launches $25 million pre-Seed fund for its home-grown startups

The University of Sydney has launched a $25 million pre-seed fund to back ventures spun out of its research, naming five initial investments across carbon capture, diabetes treatment, inhaled medicines and cardiovascular devices.

Startup Daily 5 May 2025 Endo Axiom ProKardia University of Sydney Medical Research Future Fund Net Zero Institute CUREator MTPConnect Professor Deanna D'Alessandro Prof Gemma Figtree Professor Julie Cairney Dr Nicholas Hunt

Funding announcement

FUNDED April 2023

Techboard's monthly roundup counts 40 Australian startup raises worth $498m in April 2023, headlined by Saluda Medical and Eucalyptus, plus smaller rounds and fund closes by Purpose Ventures and Proto Axiom.

Something wrong? Tell us